|
Haptides™
Haptides™ are new active peptides (10 - 20 amino acids long), homologues to sequences in the
|
|
|
|
Control non-Haptide coated sepharose beads with endothelial cells.
|
Haptide coated sepharose beads attached to endothelial cells.
|
carboxy terminal chains of fibrinogen. Some of the technological attributes of these new peptides include:
Haptide coated sepharose beads attached to endothelial cells.
• The ability to elict attachment responses from a wide range of cell types.
• The ability to be coupled to natural or synthetic matrices to improve their cell binding capacity.
• Their ability to transduce drugs or biologicals into cells.
• Haptides™ are not immunogenic or toxic.
|
